Clinical Trial Update: Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) [Phase 3]

View source ↗

Summary

Phase 3 long-term extension study evaluating TAK-438 (vonoprazan) for preventing recurrent gastric or duodenal ulcers in patients on NSAIDs; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcers
• Gastric Ulcers

Drugs mentioned

• Takecab (tegoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric Ulcers, Duodenal Ulcers | Phase 3 | Status: COMPLETED